Over 200 sea sponges were tested and a compound that caused changes in cells extracted from Parkinson's disease patients was identified, scientists at Queensland's Griffith University were quoted as saying by a ABC news report.
Using a new method, the researchers are testing over 200,000 natural compounds.
"The results are promising, but there are more than 200,000 samples left to test," researcher Ronald Quinn said.
"We've developed a technique using spectroscopy to look for something that's novel, so that part of it gives us a compound that has not been found previously by anyone else, so it's unique," he said.
Also Read
"When we looked at those 220 using this MMR fingerprinting, that allowed us to see which of those 220 had an unique component and that really allowed us to hone, and isolate and identify this compound that's new," Quinn said.
The technique could be used to treat a variety of conditions, but is a way off yet.
"In this study if we get one [compound] out of 200 - and we have 200,000 - that's quite a lot of potential that we can find that may help in trying to understand Parkinson's disease in this particular program," Quinn said, adding it is a tool to try to understand the biology behind the Parkinson's disease.
"Any therapeutic use or drug use is well down the track. We're trying to find within that haystack if you like - the needle - the single compound that's quite unique and different and can be useful to be developed towards understanding the disease, and then later on to try to treat the disease," he said.
"Because it's producing chemicals for protection and other functions, then those compounds may be useful in a therapeutic sense on a human target," he said.